Clin2
NCT07606976Likely a fitNot yet recruiting

Safety study of SSS68 injection in healthy adults

Healthy

This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
50 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Be between 18 and 45 years old
  • Weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female
  • Have normal or near-normal results on physical exams, blood work, and heart tests
  • Have no serious medical conditions, infections, or immune system problems
  • Test negative for hepatitis B, hepatitis C, and HIV
  • Not be pregnant or planning to become pregnant for 6 months after the injection

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07487545Not yet recruiting· Phase 1
Safety study of SSS67 in healthy adults

This study tests a new drug called SSS67 given as a single injection into a vein. It aims to see how safe it is in healthy adults and how the body processes it.

Charlestown, New South Wales
NCT07040046Recruiting· Phase 1
Study of HS-10542 in healthy volunteers

This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.

Qingdao, Shandong
NCT07366866Recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.

Shanghai, Shanghai Municipality
NCT07473570Recruiting· Phase 1
Safety study of GS3-007a in healthy adults

This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.

Shanghai, Shanghai Municipality
NCT07058779Recruiting· Phase 1
Safety study of SSS55 in healthy volunteers

This trial is testing a new medicine called SSS55 in healthy adults to see if it is safe and how the body processes it. Participants will receive meningococcal and pneumococcal vaccines before the study.

Shanghai, Shanghai Municipality
NCT07412353Recruiting· Phase 1
Testing safety of single dose SYH2085 in healthy people

This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.

Shanghai, Shanghai Municipality

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.